Donaldson Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.27M | Buy |
52,832
+3,527
| +7% | +$92.3K | 0.04% | 154 |
|
|
2026
Q1 | $1.38M | Buy |
49,305
+7,537
| +18% | +$201K | 0.04% | 125 |
|
|
2025
Q4 | $1.04M | Sell |
41,768
-541
| -1% | -$13.6K | 0.03% | 140 |
|
|
2025
Q3 | $1.08M | Buy |
42,309
+653
| +2% | +$16.1K | 0.03% | 140 |
|
|
2025
Q2 | $1.01M | Buy |
41,656
+2,884
| +7% | +$67.3K | 0.04% | 139 |
|
|
2025
Q1 | $982K | Buy |
38,772
+3,078
| +9% | +$80.5K | 0.04% | 136 |
|
|
2024
Q4 | $947K | Buy |
35,694
+410
| +1% | +$11.1K | 0.04% | 137 |
|
|
2024
Q3 | $1.02M | Sell |
35,284
-3,967
| -10% | -$116K | 0.04% | 129 |
|
|
2024
Q2 | $1.1M | Buy |
39,251
+5,454
| +16% | +$150K | 0.05% | 123 |
|
|
2024
Q1 | $938K | Sell |
33,797
-107
| -0.3% | -$2.97K | 0.04% | 124 |
|
|
2023
Q4 | $976K | Sell |
33,904
-1,918
| -5% | -$58K | 0.04% | 124 |
|
|
2023
Q3 | $1.19M | Sell |
35,822
-21,322
| -37% | -$754K | 0.06% | 113 |
|
|
2023
Q2 | $2.1M | Sell |
57,144
-91,732
| -62% | -$3.57M | 0.1% | 85 |
|
|
2023
Q1 | $6.07M | Sell |
148,876
-376,831
| -72% | -$16.3M | 0.29% | 49 |
|
|
2022
Q4 | $26.9M | Buy |
525,707
+4,524
| +0.9% | +$217K | 1.31% | 31 |
|
|
2022
Q3 | $22.8M | Sell |
521,183
-429,996
| -45% | -$20.9M | 1.25% | 32 |
|
|
2022
Q2 | $49.9M | Buy |
951,179
+17,565
| +2% | +$895K | 2.57% | 13 |
|
|
2022
Q1 | $48.3M | Sell |
933,614
-336,158
| -26% | -$17.4M | 2.2% | 17 |
|
|
2021
Q4 | $75M | Buy |
1,269,772
+26,161
| +2% | +$1.3M | 3.3% | 7 |
|
|
2021
Q3 | $53.5M | Buy |
1,243,611
+45,923
| +4% | +$2.03M | 2.7% | 10 |
|
|
2021
Q2 | $46.9M | Buy |
1,197,688
+70,773
| +6% | +$2.75M | 2.4% | 18 |
|
|
2021
Q1 | $40.8M | Buy |
1,126,915
+197,615
| +21% | +$7.02M | 2.24% | 18 |
|
|
2020
Q4 | $34.2M | Sell |
929,300
-49,983
| -5% | -$1.83M | 2.02% | 23 |
|
|
2020
Q3 | $34.1M | Sell |
979,283
-1,775
| -0.2% | -$62.2K | 2.31% | 22 |
|
|
2020
Q2 | $30.4M | Buy |
981,058
+55,208
| +6% | +$1.88M | 2.21% | 22 |
|
|
2020
Q1 | $28.7M | Buy |
925,850
+35,513
| +4% | +$1.21M | 2.5% | 16 |
|
|
2019
Q4 | $33.1M | Buy |
890,337
+213,782
| +32% | +$7.61M | 2.24% | 24 |
|
|
2019
Q3 | $23.1M | Sell |
676,555
-627
| -0.1% | -$22.8K | 1.71% | 28 |
|
|
2019
Q2 | $27.8M | Buy |
677,182
+2,596
| +0.4% | +$103K | 2.31% | 23 |
|
|
2019
Q1 | $27.2M | Sell |
674,586
-129,231
| -16% | -$5.18M | 2.42% | 23 |
|
|
2018
Q4 | $33.3M | Buy |
803,817
+23,558
| +3% | +$978K | 3.39% | 6 |
|
|
2018
Q3 | $32.6M | Buy |
780,259
+21,724
| +3% | +$836K | 2.85% | 12 |
|
|
2018
Q2 | $26.1M | Buy |
758,535
+5,675
| +0.8% | +$194K | 2.54% | 18 |
|
|
2018
Q1 | $25.4M | Buy |
752,860
+9,899
| +1% | +$340K | 2.49% | 20 |
|
|
2017
Q4 | $25.5M | Buy |
742,961
+30,240
| +4% | +$1.03M | 2.49% | 20 |
|
|
2017
Q3 | $24.1M | Buy |
712,721
+54,241
| +8% | +$1.74M | 2.53% | 19 |
|
|
2017
Q2 | $21M | Buy |
658,480
+13,455
| +2% | +$424K | 2.38% | 23 |
|
|
2017
Q1 | $20.9M | Buy |
645,025
+77,796
| +14% | +$2.45M | 2.43% | 22 |
|
|
2016
Q4 | $17.5M | Buy |
567,229
+21,639
| +4% | +$661K | 2.15% | 24 |
|
|
2016
Q3 | $17.5M | Buy |
545,590
+73,730
| +16% | +$2.47M | 2.32% | 23 |
|
|
2016
Q2 | $15.8M | Buy |
471,860
+464,022
| +5,920% | +$14.8M | 2.19% | 25 |
|
|
2016
Q1 | $220K | Sell |
7,838
-6,988
| -47% | -$200K | 0.03% | 134 |
|
|
2015
Q4 | $454K | Sell |
14,826
-17,810
| -55% | -$560K | 0.07% | 98 |
|
|
2015
Q3 | $973K | Buy |
32,636
+9,062
| +38% | +$291K | 0.15% | 62 |
|
|
2015
Q2 | $750K | Buy |
23,574
+1,797
| +8% | +$58.6K | 0.11% | 79 |
|
|
2015
Q1 | $719K | Sell |
21,777
-5,092
| -19% | -$162K | 0.1% | 77 |
|
|
2014
Q4 | $794K | Buy |
26,869
+7,940
| +42% | +$228K | 0.12% | 74 |
|
|
2014
Q3 | $531K | Buy |
18,929
+1,236
| +7% | +$34.7K | 0.08% | 86 |
|
|
2014
Q2 | $498K | Sell |
17,693
-1,984
| -10% | -$56.6K | 0.08% | 87 |
|
|
2014
Q1 | $600K | Sell |
19,677
-3,333
| -14% | -$99.4K | 0.11% | 72 |
|
|
2013
Q4 | $669K | Buy |
23,010
+7,631
| +50% | +$222K | 0.13% | 63 |
|
|
2013
Q3 | $419K | Sell |
15,379
-1,429
| -9% | -$38.9K | 0.09% | 69 |
|
|
2013
Q2 | $447K | Buy |
+16,808
| New | +$464K | 0.1% | 67 |
|
Other funds holding PFE
Donaldson Capital Management's PFE Position: Q2 2026 in Review
Donaldson Capital Management increased its Pfizer (PFE) stake by 7.2% in Q2 2026, buying an estimated $92.3K and bringing the position to 52,832 shares worth $1.27M. The position accounts for 0.04% of the portfolio, ranked #154.
Donaldson Capital Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $75M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Donaldson Capital Management held 52,832 shares of Pfizer worth $1.27M as of Q2 2026.
- Donaldson Capital Management bought 3,527 Pfizer shares in Q2 2026, an estimated $92.3K.
- Pfizer made up 0.04% of Donaldson Capital Management's portfolio in Q2 2026, its #154 holding.
- Donaldson Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Donaldson Capital Management's Pfizer position peaked at $75M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Donaldson Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.